Identification of Serum Metabolites for Predicting Chronic Kidney Disease Progression according to Chronic Kidney Disease Cause

Early detection and proper management of chronic kidney disease (CKD) can delay progression to end-stage kidney disease. We applied metabolomics to discover novel biomarkers to predict the risk of deterioration in patients with different causes of CKD. We enrolled non-dialytic diabetic nephropathy (...

Descripció completa

Dades bibliogràfiques

Autors principals:	Eunjeong Kang, Yufei Li, Bora Kim, Ki Young Huh, Miyeun Han, Jung-Hyuck Ahn, Hye Youn Sung, Yong Seek Park, Seung Eun Lee, Sangjun Lee, Sue K. Park, Joo-Youn Cho, Kook-Hwan Oh
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-11-01
Col·lecció:	Metabolites
Matèries:	chronic kidney disease disease progression metabolomics serum biomarkers
Accés en línia:	https://www.mdpi.com/2218-1989/12/11/1125
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!